Cargando…

Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase

OBJECTIVE: The low investment in research, diagnosis and treatment are factors that contribute to the continuity of Chagas’ disease as a neglected tropical diseases (NTDs). In this context, the repositioning of drugs represents a useful strategy, in the search for new chemotherapeutic approaches for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castilho, Vanessa V. S., Gonçalves, Keyla C. S., Rebello, Karina M., Baptista, Luiz P. R., Sangenito, Leandro S., Santos, Helena L. C., Branquinha, Marta H., Santos, André L. S., Menna-Barreto, Rubem F. S., Guimarães, Ana C., d’Avila-Levy, Claudia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249910/ https://www.ncbi.nlm.nih.gov/pubmed/30463602 http://dx.doi.org/10.1186/s13104-018-3927-z

Ejemplares similares

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors
por: Sangenito, Leandro Stefano, et al.
Publicado: (2022)

Decoding the Anti-Trypanosoma cruzi Action of HIV Peptidase Inhibitors Using Epimastigotes as a Model
por: Sangenito, Leandro S., et al.
Publicado: (2014)

Lopinavir and Nelfinavir Induce the Accumulation of Crystalloid Lipid Inclusions within the Reservosomes of Trypanosoma cruzi and Inhibit Both Aspartyl-Type Peptidase and Cruzipain Activities Detected in These Crucial Organelles
por: Sangenito, Leandro S., et al.
Publicado: (2021)

HIV Aspartyl Peptidase Inhibitors Interfere with Cellular Proliferation, Ultrastructure and Macrophage Infection of Leishmania amazonensis
por: Santos, Lívia O., et al.
Publicado: (2009)

MDL28170, a Calpain Inhibitor, Affects Trypanosoma cruzi Metacyclogenesis, Ultrastructure and Attachment to Rhodnius prolixus Midgut
por: Ennes-Vidal, Vítor, et al.
Publicado: (2011)

Analysis of Peptidases in Non-Infected and Trypanosoma cruzi-Infected Mouse Embryo Hepatocyte Cells
por: de Melo, Ana Cristina Nogueira, et al.
Publicado: (2008)

Participation of Trypanosoma cruzi gp63 molecules on the interaction with Rhodnius prolixus
por: Rebello, Karina M., et al.
Publicado: (2019)

Expression and cellular localisation of Trypanosoma cruzi calpains
por: Ennes-Vidal, Vítor, et al.
Publicado: (2020)

In Vitro Effects of Aminopyridyl Ligands Complexed to Copper(II) on the Physiology and Interaction Process of Trypanosoma cruzi
por: Silva-Oliveira, Rafaela, et al.
Publicado: (2023)

Aspartic Peptidases of Human Pathogenic Trypanosomatids: Perspectives and Trends for Chemotherapy
por: Santos, L.O., et al.
Publicado: (2013)

Susceptibility of Phytomonas serpens to calpain inhibitors in vitro: interference on the proliferation, ultrastructure, cysteine peptidase expression and interaction with the invertebrate host
por: de Oliveira, Simone Santiago Carvalho, et al.
Publicado: (2016)

Integrated Activity and Genetic Profiling of Secreted Peptidases in Cryptococcus neoformans Reveals an Aspartyl Peptidase Required for Low pH Survival and Virulence
por: Clarke, Starlynn C., et al.
Publicado: (2016)

Trypanosoma cruzi Presenilin-Like Transmembrane Aspartyl Protease: Characterization and Cellular Localization
por: Lechuga, Guilherme C., et al.
Publicado: (2020)

An Essential Signal Peptide Peptidase Identified in an RNAi Screen of Serine Peptidases of Trypanosoma brucei
por: Moss, Catherine X., et al.
Publicado: (2015)

Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Trypanosoma cruzi-Triggered Disease
por: Dantas-Pereira, Luíza, et al.
Publicado: (2021)

Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism of Leishmania amazonensis promastigotes
por: Rebello, Karina M., et al.
Publicado: (2018)

Role of the Trypanosoma brucei natural cysteine peptidase inhibitor ICP in differentiation and virulence
por: Santos, Camila C, et al.
Publicado: (2007)

Cruzipain Promotes Trypanosoma cruzi Adhesion to Rhodnius prolixus Midgut
por: Uehara, Lívia Almeida, et al.
Publicado: (2012)

Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients
por: Santos, Lívia O., et al.
Publicado: (2013)

Chagas Disease Control—Many Approaches to Prospect
por: Branquinha, Marta H., et al.
Publicado: (2023)

Trypanosoma cruzi mitochondrial swelling and membrane potential collapse as primary evidence of the mode of action of naphthoquinone analogues
por: Salomão, Kelly, et al.
Publicado: (2013)

TrypanocidalActivity of Natural Sesquiterpenoids Involves Mitochondrial Dysfunction, ROS Production and Autophagic Phenotype in Trypanosoma cruzi
por: Bombaça, Ana Cristina Souza, et al.
Publicado: (2018)

Structure of human aspartyl aminopeptidase complexed with substrate analogue: insight into catalytic mechanism, substrate specificity and M18 peptidase family
por: Chaikuad, Apirat, et al.
Publicado: (2012)

Why calpain inhibitors are interesting leading compounds to search for new therapeutic options to treat leishmaniasis?
por: ENNES-VIDAL, VITOR, et al.
Publicado: (2017)

Funding for Chagas Disease: A 10-Year (2009–2018) Survey
por: Sangenito, Leandro S., et al.
Publicado: (2020)

Fonsecaea pedrosoi Sclerotic Cells: Secretion of Aspartic-Type Peptidase and Susceptibility to Peptidase Inhibitors
por: Palmeira, Vanila F., et al.
Publicado: (2018)

Re-emerging Aspartic Protease Targets: Examining Cryptococcus neoformans Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery
por: Kryštůfek, Robin, et al.
Publicado: (2021)

Origins of peptidases
por: Rawlings, Neil D., et al.
Publicado: (2019)

Trypanosoma janseni n. sp. (Trypanosomatida: Trypanosomatidae) isolated from Didelphis aurita (Mammalia: Didelphidae) in the Atlantic Rainforest of Rio de Janeiro, Brazil: integrative taxonomy and phylogeography within the Trypanosoma cruzi clade
por: Lopes, Camila Madeira Tavares, et al.
Publicado: (2018)

Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection
por: Cascabulho, Cynthia M, et al.
Publicado: (2020)

Adaptation of Helicoverpa armigera to Soybean Peptidase Inhibitors Is Associated with the Transgenerational Upregulation of Serine Peptidases
por: Velasquez-Vasconez, Pedro A., et al.
Publicado: (2022)

Coronavirus Papain-like Peptidases
por: Ratia, Kiira, et al.
Publicado: (2013)

Trypanosoma brucei rhodesiense Inhibitor of Cysteine Peptidase (ICP) Is Required for Virulence in Mice and to Attenuate the Inflammatory Response
por: Costa, Tatiana F. R., et al.
Publicado: (2022)

Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B
por: Branquinha, Marta H., et al.
Publicado: (2022)

The role of conserved residues of chagasin in the inhibition of cysteine peptidases
por: dos Reis, Flavia C.G., et al.
Publicado: (2008)

Potential Role of Dipeptidyl Peptidase IV in the Pathophysiology of Heart Failure
por: Salles, Thiago A., et al.
Publicado: (2015)

MEROPS: the peptidase database
por: Rawlings, Neil D., et al.
Publicado: (2008)

MEROPS: the peptidase database
por: Rawlings, Neil D., et al.
Publicado: (2006)

MEROPS: the peptidase database
por: Rawlings, Neil D., et al.
Publicado: (2010)

Cell-Surface Peptidases
por: Mentlein, Rolf
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_3farevcdshjdfadu47gfr7ehm5